article thumbnail

Drug Channels News Roundup, April 2022: 340Boom, 340B Profits for Pharmacies & PBMs, Fixing Insulin, Walgreens’ Robots, and Doctors’ Day

Drug Channels

In this issue: Green Monster : The 340B market hits new highs in 2021 Not-Free Agents : Big 340B profits for CVS, Walgreens, Express Scripts, et al Batter Up : Fixing the insulin market Pinch Hitters : Walgreens bets on robots Plus, Dr. Glaucomflecken helps UnitedHealthcare celebrate Doctors’ Day!

article thumbnail

Novo Nordisk launches first smart insulin pens for NHS patients

pharmaphorum

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time. Smart insulin pens are expected to drive the insulin pen market from $13.8

Insulin 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Longevity Breakthrough Your Doctor Won't Tell You About

The Pharma Data

Product Name: The Longevity Breakthrough Your Doctor Won't Tell You About. Click here to get The Longevity Breakthrough Your Doctor Won't Tell You About at discounted price while it’s still available… All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors.

Doctors 52
article thumbnail

Sanofi extends Health2Sync digital diabetes partnership to Japan

pharmaphorum

Digital health company Health2Sync will work with Sanofi on digitising its range of insulin products in Japan, extending an earlier alliance in other markets. The new Japanese alliance will however go a step further. “Patients are receiving an average of 14.8 “Patients are receiving an average of 14.8

Insulin 52
article thumbnail

Medtronic Introduces New Minimed 770G For Type 1 Diabetes

XTalks

This is an insulin pump system that offers the company’s most advanced SmartGuard technology. ” The pancreas of people with type 1 diabetes cannot produce insulin. “Being able to offer my patients an insulin pump system that provides safe, automated insulin delivery and smartphone connectivity is incredibly beneficial.”.

Insulin 98
article thumbnail

Health2Sync and Sanofi to digitally manage diabetes in Taiwan

pharmaphorum

But use of insulin is relatively low compared with American and European countries and there are an estimated 2.2 The ultimate goal is to improve patients’ understanding of insulin, increase glucose control and raise the insulinisation rate in Taiwan. million diabetes patients in Taiwan.

Insulin 76
article thumbnail

Roche debuts smart glucose monitor for hospital use

pharmaphorum

Roche has launched what it says is a first-of-its kind handheld glucose management device, backed up by a digital platform that aims to simplify the work of doctors and nurses as they deliver care to patients. The post Roche debuts smart glucose monitor for hospital use appeared first on.

Insulin 128